Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
The U.S. Seeks a Regulatory Framework for CBD
Establishing a regulatory framework for CBD, consumer safety, production quality, the 2022 omnibus spending bill, and Vantage's DMF filing.
The Revitalization of Hemp: A Regulatory Evolution
Dive into the establishment of US hemp policy and the importance of selecting a pharmaceutically proficient CBD extractor and contract manufacturer.
A Global Shift for Manufacturers: The International Demand for cGMP Compliance
Companies that look to meet global manufacturing demand are required to be regulatory compliant across all regions of interest.